Navigation Links
B. Braun To Sponsor Workshop and Platinum Showcase at AVA
Date:9/3/2014

BETHLEHEM, Pa., Sept. 3, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will exhibit and host a Pre-Meeting Workshop and Platinum Showcase presentation at the 28th Association for Vascular Access (AVA) Annual Scientific Meeting in National Harbor, Maryland, September 7th-10th.

B.Braun, along with Analogic Corporation, is supporting a Pre-Meeting Workshop titled, "Ultrasound Guided Upper Extremity Simulation Workshop," on Saturday, September 6th from 1:00 – 5:00 p.m. at the Gaylord National Resort & Convention Center. Dr. Robert B. Dawson, DNP, MSA, APRN, ACNP-BC, CPUI, VA-BC, Vascular Access Consultant, PICC Academy and Nancy L. Moureau, BSN, CRNI, CPUI, VA-BC, President & CEO, PICC Excellence, Inc. will present. The Right Triangle Method will be featured, as well as the 45/50 rule for ultrasound peripheral catheter insertion to ensure optimal procedure success. This skills lab will reinforce both in plane and out of plane access for peripheral veins of the mid-forearm and upper arm.

Dr. Dawson will also be a featured presenter during the Platinum Showcase sessions. Dr. Dawson's session presentation, "Maximizing Peripheral Access Success: Featuring Clinical Application of Evidence using a Practice Framework," will provide a comprehensive overview on how to implement peripheral vascular access for the least risk to the patient to help achieve optimal outcomes. The presentation will take place on Monday, September 8th, 2014 from 3:30 – 4:30 p.m. at the Gaylord National Resort & Convention Center Potomac Room 3-4. B.Braun is also a proud sponsor of AVA foundation's annual fund raiser Connect the Dots, which supports education and research.

"Catheter-related bloodstream infections, needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major issues facing all healthcare professionals," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. "We are committed to combating these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety for clinicians in the workplace," added Sutton.

Dr. Dawson will be the featured expert at B.Braun's booth where he will demonstrate his 45/50 rule for ultrasound peripheral vascular access on Monday, September 8th (1:15 – 2:15 p.m.), Tuesday, September 9th (12:15 – 1:15 p.m.), and Wednesday, September 10th (12:30 – 1:30 p.m.). In addition, B.Braun will demonstrate the following safety-engineered IV therapy devices at booth (#110) during AVA. 

  • Introcan Safety® IV Catheter, which is designed with innovative passive-safety features to help eliminate accidental needlestick injury - effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically - no extra steps required and cannot be bypassed.
  • Introcan Safety® 3 Closed IV Catheter, B.Braun's latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed.
  • InVision-Plus® Neutral IV Connector, the latest addition to the B.Braun needleless connector portfolio through an exclusive U.S. distribution agreement with RyMed Technologies, LLC, provides a 10-point standard of features. B.Braun's portfolio of needleless connectors, including the CARESITE® Luer Access Device, offers a safe way to access IV lines through innovative features designed to help reduce catheter occlusions while protecting healthcare workers from accidental needlestick injuries.

To learn more about B. Braun's activities at AVA, please visit www.bbraunava.com.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com

 


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Joins National Health Organization Supporting Environmental Practices
2. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
3. B. Braun Launches New Patient Website
4. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
5. B. Braun Reveals Customer Satisfaction Survey
6. B. Braun Committed To Improving Patient Safety
7. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
8. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
9. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
10. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
11. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs ... benchmarks in the global Oesophageal Cancer market. The research ... the key drugs marketed for Oesophageal Cancer and their clinical attributes? ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency ... Belmont, and Palo Alto, is proud to announce an important upgrade to its geographic ... for home care close to home, and by having city-specific pages, NuevaCare is answering ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today ... 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical ... behavioral health analytics to improve Medicaid population health management. , ODH will also have ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
Breaking Medicine News(10 mins):